Skip to main content

Advertisement

SpringerLink
Log in

The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: Positive and negative effects

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

The role of glucocorticoids in bone formation presents a problem because although pharmacological doses in vivo give rise to osteoporosis, physiological concentrations are required for osteoblast (OB) differentiation in vitro. To try and rationalize this dichotomy, we investigated the effect of dexamethasone on the recruitment of OB precursors present in bone marrow. Using the CFU-f assay, we can measure (1) total colony formation; (2) the osteoblastic differentiation of the colonies defined as their ability to express alkaline phosphatase, synthesize collagen, and to calcify; and (3) colony expansion as either average colony surface area or average colony number. In control cultures and in the presence of 10−10-10−9 M dexamethasone, colony formation and total cell number was maximal, but the addition of PGE2 had no effect on colony number and very few colonies expressed the OB phenotype. In the presence of 10−8-10−7 M dexamethasone, colony numbers and total cell numbers were reduced but were increased by the addition of PGE2, the average colony cell number and surface area were relatively unchanged and a proportion of the colonies expressed APase, calcified and synthesized collagen. In cultures containing 10−6-10−5 M dexamethasone, colony numbers were further reduced but were stimulated by the addition of PGE2 and some colonies differentiated; however, colony expansion was dramatically reduced by up to 80%. These results suggest that physiological levels of glucocorticoids are necessary for OB differentiation and allow the control of OB recruitment by PGE2. High levels of glucocorticoids drastically reduce proliferation of the OB precursors leading to glucocorticoid-induced osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hodgson SF (1990) Corticosteroid-induced osteoporosis. Endocrinol Metab Clin North Am 19:95–111

    PubMed  CAS  Google Scholar 

  2. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112: 352–364

    PubMed  CAS  Google Scholar 

  3. Mitchell DR, Lyles KW (1990) Glucocorticoid-induced osteoporosis: mechanism for bone loss; evaluation of strategies for prevention. J Gerontol 45:M153–158

    PubMed  CAS  Google Scholar 

  4. Hope RA, Longmore JM (1988) Oxford Handbuch der Klinischen Medizin. Verlag Hans Huber, Bern, Stuttgart, Toronto

  5. Bellows CJ, Aubin JE, Heersche JNM (1987) Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvarial cells in vitro. Endocrinology 121:1985–1992

    PubMed  CAS  Google Scholar 

  6. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV (1994) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277–286

    Article  PubMed  CAS  Google Scholar 

  7. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I (1994) Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218–228

    Article  PubMed  Google Scholar 

  8. Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull John Hopkins Hosp 50:137–195

    Google Scholar 

  9. Swartz SL, Dluhy RG (1978) Corticosteroids: clinical pharmacology and therapeutic use. Drugs 16:238–255

    Article  PubMed  CAS  Google Scholar 

  10. Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309: 265–268

    PubMed  CAS  Google Scholar 

  11. Reugsegger P, Medici TC, Anliker M (1983) Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615–620

    Article  Google Scholar 

  12. Ross EJ, Linch DC (1982) Cushing’s syndrome-killing disease: discriminatory value of early signs and symptoms aiding early diagnosis. Lancet 2:646–649

    Article  PubMed  CAS  Google Scholar 

  13. Ferretti JL, Vazquez SO, Delgado CJ, Capozza R, Cointry G (1992) Biphasic dose-response curves of cortisol effects on rat diaphyseal bone biomechanics. Calcif Tissue Int 50:49–54

    Article  PubMed  CAS  Google Scholar 

  14. LaBorde JB, Hansen DK, Young JF, Sheehan DM, Holson RR (1992) Prenatal effects of dose, age at exposure, and drug-induced hypophagia on malformations and fetal organ weights. Fundam Appl Toxicol 19:545–554

    Article  PubMed  CAS  Google Scholar 

  15. Binz K, Schmid C, Buoillon R, Froesch ER, Jurgensen K, Hunziker EB (1994) Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density and mineral metabolism in rats. Eur J Endocrinol 130:387–393

    Article  PubMed  CAS  Google Scholar 

  16. Chavassieux P, Pastoureau P, Chapuy MC, Delmas PD, Meunier PJ (1993) Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study. Osteoporosis Int 3:97–102

    Article  CAS  Google Scholar 

  17. Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB Jr (1992) Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 263:E489–492

    PubMed  CAS  Google Scholar 

  18. Altman A, Hochberg Z, Silbermann M (1992) Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse. Calcif Tissue Int 51:298–304

    Article  PubMed  CAS  Google Scholar 

  19. Reid IR (1989) Steroid osteoporosis. Calcif Tissue Int 45:63–67

    Article  PubMed  CAS  Google Scholar 

  20. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edourd E, Darby AJ (1979) Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1:303–319

    Article  Google Scholar 

  21. Dempster DW, Arlot MA, Meunier PJ (1983) Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 35:410–417

    Article  PubMed  CAS  Google Scholar 

  22. Reid IR, Chapman GE, Fraser TRC, Davies AD, Surus AS, Meyer J, Huq NL, Ibbertson HK (1986) Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metabol 62:379–383

    CAS  Google Scholar 

  23. Feldman D, Dziak R, Koehler R, Stern P (1975) Cytoplasmic glucocorticoid binding proteins in bone cells. Endocrinology 96:29–35

    PubMed  CAS  Google Scholar 

  24. Chen TL, Feldman D (1979) Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. J Clin Invest 63:750–758

    Article  PubMed  CAS  Google Scholar 

  25. Chen TL, Aronow L, Feldman D (1977) Glucocorticoid receptors and inhibition of bone cell growth in primary culture. Endocrinology 100:619–626

    PubMed  CAS  Google Scholar 

  26. Wong GL (1979) Basal activities and hormone responsiveness of osteoblast-like and osteoclast-like bone cells are regulated by glucocorticoids. J Biol Chem 254:6337–6343

    PubMed  CAS  Google Scholar 

  27. Canalis E (1983) Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology 112:931–939

    PubMed  CAS  Google Scholar 

  28. Chyun YS, Kream BE, Raisz LG (1984) Cortisol decreases bone formation by inhibiting periosteal cell proliferation. Endocrinology 114:477–480

    PubMed  CAS  Google Scholar 

  29. Majeska RJ, Rodan GA (1981) Hormonal regulation of alkaline phosphatase in an osteoblastic osteosarcoma line. Calcif Tissue Int 33:297–308

    Google Scholar 

  30. Majeska RJ, Nair BC, Rodan GA (1985) Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17/2.8. Endocrinology 116:170–179

    PubMed  CAS  Google Scholar 

  31. Owen M (1985) Lineage of osteogenic cells and their relationship to the stromal system. In: Peck WA (ed) Bone and mineral research, vol 3. Elsevier Amsterdam, pp 1–25

  32. Friedenstein AJ (1990) Osteogenic stem cells in the bone marrow. Bone Miner Res 7:243–272

    Google Scholar 

  33. Leboy PS, Beresford JN, Devlin C, Owen ME (1991) Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J Cell Physiol 146:370–378

    Article  PubMed  CAS  Google Scholar 

  34. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME (1992) Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102:341–351

    PubMed  CAS  Google Scholar 

  35. Maniatopoulos C, Sodek J, Melcher AH (1988) Bone formation in vitro by stromal cells obtained from bone marrow of young rats. Cell Tissue Res 254:317–330

    Article  PubMed  CAS  Google Scholar 

  36. Satomura K, Nagayama M (1991) Ultrastructure of mineralized nodules formed in rat bone marrow stromal cell culture in vitro. Acta Anat (Basel) 142:97–104

    Article  CAS  Google Scholar 

  37. Scutt A, Bertram P (1995) Bone marrow cells are targets for the anabolic actions of PGE2: induction of a transition from non-adherent to adherent osteoblast precursors. J Bone Miner Res 10:474–487

    Article  PubMed  CAS  Google Scholar 

  38. Bancroft DJ, Stevens A (1982) Theory and practice of histological techniques, 2nd ed. Churchill Livingstone.

  39. Lopez-de Leon A, Rojkind M (1985) A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33:737–743

    Google Scholar 

  40. Currie GA (1981) Platelet-derived growth factor requirements for in vitro proliferation of normal and malignant cells. Br J Cancer 43:335–343

    PubMed  CAS  Google Scholar 

  41. Nefussi J-R, Boy-Lefevre ML, Boolekbache H, Forest N (1985) Mineralization in vitro of matrix formed by osteoblasts isolated by collagenase digestion. Differentiation 29:160–168

    Article  PubMed  CAS  Google Scholar 

  42. Bellows CG, Aubin JE, Heersche JNM, Antosz ME (1986) Mineralised bone nodules formed in vitro from enzymatically released rat calvarial cell populations. Calcif Tissue Int 38: 143–154

    Article  PubMed  CAS  Google Scholar 

  43. Stein GS, Lian JB, Owen TA (1990) Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111–3123

    PubMed  CAS  Google Scholar 

  44. Bellows CG, Aubin JE (1989) Determination of numbers of osteoprogenitors present in isolated fetal rat calvarial cells in vitro. Dev Biol 133:8–13

    Article  PubMed  CAS  Google Scholar 

  45. Benayahu D, Kletter Y, Zipori D, Weintroub S (1989) Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo. J Cell Physiol 140:1–7

    Article  PubMed  CAS  Google Scholar 

  46. Barling PM, Bennett JH, Triffitt JH, Owen ME (1989) The adenylate cyclase response to parathyroid hormone in cultured rabbit marrow fibroblastic cells. Bone Miner 7:23–30

    Article  PubMed  CAS  Google Scholar 

  47. Simmons DJ, Seitz P, Kidder L, Klein GL, Waeltz M, Gundberg CM, Tabuchi C, Yang C, Zhang RW (1991) Partial characterization of rat marrow stromal cells. Calcif Tissue Int 48:326–334

    Article  PubMed  CAS  Google Scholar 

  48. Chen TL, Feldman D (1984) Modulation of PTH-stimulated cyclic AMP in cultured rodent bone cells: the effects of 1,25-(OH)2 vitamin D3 and its interaction with glucocorticoids. Calcif Tissue Int 36:580–585

    Article  PubMed  CAS  Google Scholar 

  49. Catherwood BD (1985) 1,25 Dihydroxycholecalciferol and glucocorticoid regulation of adenylate cyclase in an osteo-blast-like cell line. J Biol Chem 260:736–743

    PubMed  CAS  Google Scholar 

  50. Kozawa O, Tokuda J, Kotoyori J, Oiso Y (1993) Effects of glucocorticoid on signalling by prostaglandin E2 in osteoblast-like cells. Prostaglandins Leukot Essent Fatty Acids 49:867–872

    Article  PubMed  CAS  Google Scholar 

  51. McCarthy TL, Centrella M, Canalis E (1990) Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology 126:1569–1575

    PubMed  CAS  Google Scholar 

  52. Chen TL, Mallory JB, Hintz RL (1991a) Dexamethasone and 1,25(OH)2 vitamin D3 modulate the synthesis of insulin-like growth factor-I in osteoblast-like cells. Calcif Tissue Int 48: 278–282

    Article  PubMed  CAS  Google Scholar 

  53. Chen TL, Chang LY, Bates RL, Perlaman AJ (1991b) Dexamethasone and 1,25-dihydroxyvitamin D3 modulation of in-162 sulin-like growth factor-binding proteins in rat osteoblast-like cell cultures. Endocrinology 128:73–80

    PubMed  CAS  Google Scholar 

  54. Okazaki R, Riggs BL, Conover CA (1994) Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. Endocrinology 134:126–132

    Article  PubMed  CAS  Google Scholar 

  55. Chyun YS, Raisz LG (1984) Stimulation of bone formation by prostaglandin E2. Prostaglandins 27:97–103

    Article  PubMed  CAS  Google Scholar 

  56. Nefussi J-R, Baron R (1985) PGE2 stimulates both resorption and formation of bone in vitro: differential responses of the periosteum and the endosteum in fetal rat long bone cultures. Anat Rec 211:9–16

    Article  PubMed  CAS  Google Scholar 

  57. Raisz LG, Fall PM (1990) Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 126:1654–1659

    PubMed  CAS  Google Scholar 

  58. Raisz LG, Fall PM, Gabbitas BY, McCarthy TL, Kream BE, Canalis E (1993) Effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: role of insulin-like growth factor-I. Endocrinology 133:1504–1510

    Article  PubMed  CAS  Google Scholar 

  59. Mahy PR, Urist MR (1988) Experimental heterotopic bone formation induced by bone morphogenetic protein and recombinant interleukin-Iβ. Clin Orthop Rel Res 237:236–244

    Google Scholar 

  60. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR (1989) Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142–1150

    PubMed  CAS  Google Scholar 

  61. Takada M, Yamamoto R, Morita R (1994) Chronic intramedullary infusion of interleukin-1 alpha increases bone mineral content in rats. Calcif Tissue Int 55:103–108

    Article  PubMed  CAS  Google Scholar 

  62. Marusic A, Raisz LG (1991) Cortisol modulates the actions of interleukin-1 alpha on bone formation, resorption, and prostaglandin production in cultured mouse parietal bones. Endocrinology 129:2699–2706

    Article  PubMed  CAS  Google Scholar 

  63. Brum-Fernandes AJ, Laporte S, Heroux M, Lora M, Patry C, Menard H-E, Dumais R, Leduc R (1994) Expression of prostaglandin endoperoxide synthase-1 and prostaglandin endoperoxide synthase-2 in human osteoblasts. BBRC 198:955–960

    PubMed  Google Scholar 

  64. Raisz LG, Simmons HA (1985) Effects of parathyroid hormone and cortisol on prostaglandin production by neonatal rat calvaria in vitro. Endocrinol Res 11:59–65

    Article  CAS  Google Scholar 

  65. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB (1994) Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 93:2490–2496

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Schering Research Laboratories, Schering AG, 13353, Berlin, Germany

    A. Scutt, P. Bertram & M. Bräutigam

Authors
  1. A. Scutt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Bertram
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Bräutigam
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scutt, A., Bertram, P. & Bräutigam, M. The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: Positive and negative effects. Calcif Tissue Int 59, 154–162 (1996). https://doi.org/10.1007/s002239900102

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900102

Key words

Search

Navigation